Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Krailo

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Problems identified with phase II stopping rules that employ response and early-progression ratesJames R Anderson, Mark D Krailo
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Contemporary Clinical Trials|July 9, 2010
A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trialsZhengjia Chen, Mark D Krailo, Stanley P Azen, et al.
Contemporary Clinical Trials|November 13, 2008
Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology GroupZhengjia Chen, Mark D Krailo, Junfeng Sun, et al.
Pediatric Blood & Cancer|June 18, 2009
Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group studyJohn F Kuttesch, Mark D Krailo, Timothy Madden, et al.
The Lancet. Oncology|April 30, 2022
Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431Etan Orgel, Doojduen Villaluna, Mark D Krailo, et al.
Journal of Pediatric Surgery|February 9, 2021
Current surgical management of children with osteosarcoma and pulmonary metastatic disease: A survey of the American Pediatric Surgical AssociationTimothy B Lautz, Mark D Krailo, Ruxu Han, et al.
Pharmaceutical Statistics|July 26, 2023
Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcomeHa M Dang, Mark D Krailo, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Rare Tumors in Children: Progress Through CollaborationAlberto S Pappo, Wayne L Furman, Kris A Schultz, et al.
Biometrical Journal. Biometrische Zeitschrift|July 7, 2020
Information fraction estimation based on the number of events within the standard treatment regimenHa M Dang, Todd Alonzo, Meredith Franklin, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Problems identified with phase II stopping rules that employ response and early-progression ratesJames R Anderson, Mark D Krailo
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Contemporary Clinical Trials|July 9, 2010
A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trialsZhengjia Chen, Mark D Krailo, Stanley P Azen, et al.
Contemporary Clinical Trials|November 13, 2008
Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology GroupZhengjia Chen, Mark D Krailo, Junfeng Sun, et al.
Pediatric Blood & Cancer|June 18, 2009
Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group studyJohn F Kuttesch, Mark D Krailo, Timothy Madden, et al.
The Lancet. Oncology|April 30, 2022
Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431Etan Orgel, Doojduen Villaluna, Mark D Krailo, et al.
Journal of Pediatric Surgery|February 9, 2021
Current surgical management of children with osteosarcoma and pulmonary metastatic disease: A survey of the American Pediatric Surgical AssociationTimothy B Lautz, Mark D Krailo, Ruxu Han, et al.
Pharmaceutical Statistics|July 26, 2023
Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcomeHa M Dang, Mark D Krailo, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Rare Tumors in Children: Progress Through CollaborationAlberto S Pappo, Wayne L Furman, Kris A Schultz, et al.
Biometrical Journal. Biometrische Zeitschrift|July 7, 2020
Information fraction estimation based on the number of events within the standard treatment regimenHa M Dang, Todd Alonzo, Meredith Franklin, et al.
Pageof 11